Chantix Heart Problems Being Reviewed in Canada
Canadian officials have launched a review into the potential risk of heart problems from Chantix, Pfizer’s smoking cessation drug, which has been linked to an increased risk of heart attacks and other cardiac events among individuals with cardiovascular disease. …